TandemGrowth Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Hold
369
0.36% 21
2026
Q1
$339K Hold
369
0.32% 20
2025
Q4
$397K Buy
+369
New +$353K 0.35% 21

Other funds holding LLY

TandemGrowth Financial Advisors's LLY Position: Q2 2026 in Review

TandemGrowth Financial Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 369 shares worth $443K. The position accounts for 0.36% of the portfolio, ranked #21.

TandemGrowth Financial Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TandemGrowth Financial Advisors held 369 shares of Eli Lilly worth $443K as of Q2 2026.
  • TandemGrowth Financial Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.36% of TandemGrowth Financial Advisors's portfolio in Q2 2026, its #21 holding.
  • TandemGrowth Financial Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TandemGrowth Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.